A customer in (b)(6) notified biomérieux of a misidentification associated with the vitek® 2 ast-n233 test kit (reference (b)(4) involving an eeq cclin ouest strain.The customer reported the vitek® 2 ast-n233 card results were klebsiella oxytoca; however, the expected result was acinetobacter baumanii.The strain was tested twice on the vitek® 2 with the same results.In addition, the customer indicated testing with api® 20e and the result was acinetobacter baumanii.The customer indicated the discrepancy did not involve a patient or healthcare provider as it was an eeq strain that was tested.Therefore, there was no adverse events, negative impact or delays related to this discrepancy.An internal biomérieux investigation will be initiated.
|